Aug 26, 2025
THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE. The content included on this website is for informational and educational purposes only. Always consult with your healthcare provider regarding any medical condition and before starting any healthcare or medication regimen.
Wegovy (semaglutide) and Mounjaro (tirzepatide) are two of the most effective prescription medications available today for people struggling with obesity or excess weight. While both help with weight loss by regulating appetite and digestion, they work in slightly different ways and come with different costs and considerations.
In this article, we’ll compare Wegovy and Mounjaro side by side—exploring how they work, effectiveness, side effects, cost, and how to save using a CareCard prescription discount card. No insurance or sign-up is required.
These medications help with:
Chronic Weight Management: For adults with obesity (BMI ≥30) or overweight (BMI ≥27) with related health issues.
Type 2 Diabetes (Mounjaro only): Mounjaro was originally approved to improve blood sugar control in adults with type 2 diabetes but is also used off-label for weight loss.
Wegovy is a GLP-1 receptor agonist. It mimics a natural hormone that helps regulate appetite and food intake, helping users feel full sooner and reduce caloric intake.
In clinical trials, Wegovy demonstrated an average weight loss of about 15% of total body weight over 68 weeks when combined with diet and exercise. It is considered one of the most effective medications for weight management.
Weekly subcutaneous injection
Dose starts at 0.25 mg and gradually increases to 2.4 mg over 16 weeks
Common side effects of Wegovy include:
Nausea
Diarrhea
Vomiting
Constipation
Headache
Serious but rare side effects may include pancreatitis or gallbladder issues.
Wegovy may interact with:
Insulin or other diabetes medications (risk of low blood sugar)
Medications that affect digestion
Mounjaro is a dual GLP-1 and GIP receptor agonist, which makes it unique among weight loss medications. By activating both hormone pathways, it may offer superior results for both weight loss and blood sugar control.
In clinical trials, Mounjaro showed an average weight loss of 20% of total body weight over 72 weeks when combined with lifestyle changes.
Weekly subcutaneous injection
Starting dose of 2.5 mg, increasing up to 15 mg based on provider guidance
Common side effects include:
Nausea
Vomiting
Diarrhea
Decreased appetite
More serious risks include pancreatitis or severe gastrointestinal distress.
Mounjaro may interact with:
Insulin or sulfonylureas (risk of hypoglycemia)
Other medications that delay gastric emptying
Mechanism of Action: Wegovy is a GLP-1 receptor agonist, while Mounjaro combines GLP-1 and GIP receptor activity—potentially enhancing weight loss outcomes.
Effectiveness: Clinical studies show Mounjaro typically leads to greater weight loss (up to 20% of body weight) compared to Wegovy (around 15%).
Primary Use: Wegovy is FDA-approved specifically for weight management. Mounjaro is approved for type 2 diabetes but widely prescribed off-label for weight loss.
Both medications are highly effective for weight loss, but Mounjaro often delivers more dramatic results. Your choice may depend on your weight loss goals and whether blood sugar control is also a concern.
Both medications can cause nausea, vomiting, and gastrointestinal issues. However, side effects vary by individual. One medication may be better tolerated than the other depending on your personal medical history.
Wegovy: ~$1,349/month without insurance
Mounjaro: ~$1,023/month without insurance
Both medications may be more affordable with a CareCard prescription discount card.
Choosing between Wegovy and Mounjaro depends on your health goals, tolerance for side effects, and insurance coverage.
Want greater weight loss? Mounjaro may offer better results.
Prefer a medication approved specifically for weight loss? Wegovy fits that criteria.
Need blood sugar control too? Mounjaro treats both type 2 diabetes and obesity.
Worried about cost? Mounjaro is typically less expensive.
Speak with your healthcare provider to determine the safest and most effective choice for your individual needs.
If cost is a concern, you may be eligible for major savings. With CareCard, you can access free discounts on Wegovy, Mounjaro, and thousands of other prescriptions at your local pharmacy—no insurance or registration required.
Both Wegovy and Mounjaro are transforming how we treat obesity and metabolic health. While Wegovy is specifically FDA-approved for weight management, Mounjaro has shown superior weight loss results and offers additional benefits for people with type 2 diabetes.
Whichever option you and your doctor choose, you can reduce your out-of-pocket cost using a CareCard prescription discount card.
What is the difference between Wegovy and Mounjaro? Wegovy is a GLP-1 agonist approved for weight loss. Mounjaro is a dual agonist that works on both GLP-1 and GIP receptors, showing stronger weight loss results.
Which medication is more effective for weight loss? Mounjaro generally results in greater weight loss (~20%) than Wegovy (~15%).
Can I take these medications with others? Possibly, but both have drug interactions. Always talk to your provider before starting or combining medications.
How much do Wegovy and Mounjaro cost? Without insurance, Wegovy costs about $1,349/month and Mounjaro about $1,023/month. Prices vary by location and pharmacy.
How can I save on these medications? Use a CareCard prescription discount card for instant savings at local pharmacies.